Latest Trials
Latest News
FAQ
Pharmaceutical Companies
Pharma Details
ALCON RESEARCH
🇺🇸
United States
Country
🇺🇸
United States
Ownership
-
Employees
-
Market Cap
-
Website
Clinical Trials
Related News
Comparison of Two Marketed Silicone Hydrogel Lenses
Not Applicable
Completed
Conditions
Refractive Error
Interventions
Device: Lotrafilcon B contact lenses
Device: Samfilcon A contact lenses
Device: Hydrogen peroxide solution
Device: Saline solution
Subscribe
First Posted Date
2015-07-13
Last Posted Date
2016-12-28
Lead Sponsor
Alcon Research
Target Recruit Count
168
Registration Number
NCT02495948
Subscribe
Proof of Concept Study to Evaluate Safety and Efficacy of LME636 in the Treatment of Acute Anterior Uveitis
Phase 2
Completed
Conditions
Acute Anterior Uveitis
Interventions
Drug: LME636 60 mg/mL ophthalmic solution
Drug: Dexamethasone 0.1% ophthalmic solution
Drug: LME636 Vehicle
Subscribe
First Posted Date
2015-06-26
Last Posted Date
2018-07-02
Lead Sponsor
Alcon Research
Target Recruit Count
45
Registration Number
NCT02482129
Subscribe
Clinical Comparison of 27+® and 23-gauge ULTRAVIT® 7500 Cpm Vitrectomy Outcomes
Not Applicable
Completed
Conditions
Vitreoretinal Disease
Interventions
Device: CONSTELLATION® 27-gauge Combined Surgical Pak
Device: CONSTELLATION® 23-gauge Combined Surgical Pak
Procedure: Vitrectomy surgery
Subscribe
First Posted Date
2015-06-23
Last Posted Date
2018-07-02
Lead Sponsor
Alcon Research
Target Recruit Count
137
Registration Number
NCT02477605
Locations
🇺🇸
Contact Alcon Call Center for Trial Locations, Fort Worth, Texas, United States
Subscribe
Evaluation of Clinical Outcomes After the Use of SYSTANE® HYDRATION
Not Applicable
Completed
Conditions
Dry Eye
Interventions
Device: SYSTANE HYDRATION lubricant eye drops
Device: Hyabak 0.15% eye drops
Drug: 0.9% saline eye drops
Subscribe
First Posted Date
2015-06-12
Last Posted Date
2018-07-02
Lead Sponsor
Alcon Research
Target Recruit Count
114
Registration Number
NCT02470429
Subscribe
Clinical Evaluation Following Use of SYSTANE® ULTRA in the Management of Dry Eye
Not Applicable
Completed
Conditions
Dry Eye Syndrome
Interventions
Drug: SYSTANE® ULTRA Lubricant Eye Drops
Subscribe
First Posted Date
2015-05-15
Last Posted Date
2018-07-02
Lead Sponsor
Alcon Research
Target Recruit Count
159
Registration Number
NCT02446015
Subscribe
Safety and Efficacy of EXE844 Otic Suspension in Otitis Media at Time of Tympanostomy Tube Insertion (OMTT) - Study 2
Phase 3
Completed
Conditions
Otitis Media With Effusion in Children
Otitis Media Recurrent
Interventions
Drug: EXE844 Sterile Otic Suspension, 0.3%
Procedure: Tympanostomy Tube Insertion
Subscribe
First Posted Date
2015-05-06
Last Posted Date
2018-07-02
Lead Sponsor
Alcon Research
Target Recruit Count
404
Registration Number
NCT02436304
Subscribe
Efficacy and Safety of RTH258 Versus Aflibercept - Study 2
Phase 3
Completed
Conditions
Neovascular Age-Related Macular Degeneration
Choroidal Neovascularization
Interventions
Drug: Brolucizumab ophthalmic solution
Drug: Aflibercept ophthalmic solution
Subscribe
First Posted Date
2015-05-05
Last Posted Date
2020-09-11
Lead Sponsor
Alcon Research
Target Recruit Count
1048
Registration Number
NCT02434328
Subscribe
Safety and Efficacy of EXE844 Otic Suspension in Otitis Media at Time of Tympanostomy Tube Insertion (OMTT)
Phase 3
Completed
Conditions
Otitis Media With Effusion in Children
Otitis Media Recurrent
Interventions
Drug: EXE844 Sterile Otic Suspension, 0.3%
Procedure: Tympanostomy Tube Insertion
Subscribe
First Posted Date
2015-05-01
Last Posted Date
2018-07-02
Lead Sponsor
Alcon Research
Target Recruit Count
470
Registration Number
NCT02432105
Subscribe
SIMBRINZA® Suspension BID as an Adjunctive to Prostaglandin Analogue (PGA)
Phase 4
Completed
Conditions
Open-Angle Glaucoma
Ocular Hypertension
Interventions
Drug: Brinzolamide 1%/brimonidine 0.2% tartrate ophthalmic suspension
Drug: Brinz/brim vehicle
Drug: Prostaglandin analogue
Subscribe
First Posted Date
2015-04-17
Last Posted Date
2018-11-15
Lead Sponsor
Alcon Research
Target Recruit Count
290
Registration Number
NCT02419508
Locations
🇺🇸
Contact Alcon Call Center for Trial Locations, Fort Worth, Texas, United States
Subscribe
Clear Care® Plus vs. PeroxiClear™
Not Applicable
Completed
Conditions
Refractive Error
Interventions
Device: Clear Care Plus contact lens solution
Device: PeroxiClear contact lens solution
Device: Silicone hydrogel contact lenses
Subscribe
First Posted Date
2015-04-09
Last Posted Date
2016-09-19
Lead Sponsor
Alcon Research
Target Recruit Count
133
Registration Number
NCT02413333
Subscribe
Prev
1
15
16
17
18
19
61
Next
© Copyright 2024. All Rights Reserved by MedPath
Home
Terms & Conditions
Privacy Policy